Navigation Links
MedQuist Announces Resolution of SEC Investigation
Date:3/13/2009

MOUNT LAUREL, N.J., March 13 /PRNewswire-FirstCall/ -- MedQuist Inc. (Nasdaq: MEDQ), a leading provider of medical transcription services, is pleased to announce that it has resolved the investigation by the Securities and Exchange Commission (SEC) regarding the Company's historic billing practices. Pursuant to the settlement, the Company agreed to the entry of final judgment in prospective litigation by the SEC, including an injunction against the Company from violating federal securities laws. Under the settlement, the Company will not pay any fines or penalties to the SEC, and the Company does not admit to or deny any liability or wrongdoing.

As originally reported by MedQuist in 2004, the SEC opened an investigation regarding the Company's historic billing practices after the Company announced it had undertaken an internal review of its billing practices and was delaying the filing of its annual report on Form 10-K for the year ended December 31, 2003. MedQuist cooperated fully with the SEC investigation and is pleased to conclude this matter.

Resolution of the SEC investigation follows the Company's resolution of the previously disclosed Department of Justice investigation, the previously disclosed settlements reached in the South Broward customer class action, the consolidated medical transcriptionist class action, and the Steiner shareholder class action lawsuits, and dismissal with prejudice of the Kanter shareholder derivative class action. Upon court approval and entry of final judgment in the SEC matter and medical transcriptionist litigation, the Company will have completely resolved all class action litigation and governmental investigation matters arising from the internal review of its historic billing practices.

About MedQuist:

MedQuist is a leading provider of medical transcription services, and a leader in technology-enabled clinical documentation workflow. MedQuist's enterprise solutions -- including mobile voice capture devices, speech recognition, Web-based workflow platforms, and global network of medical editors -- help healthcare facilities improve patient care, increase physician satisfaction, and lower operational costs. For more information, please visit http://www.medquist.com.

"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. Actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements. As a result, forward-looking statements speak only as of the date they were made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE MedQuist Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MedQuist Reports Fourth Quarter and Year End 2008 Results
2. MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits
3. New Jersey-Based MedQuist Pays U.S. $6.6 Million to Resolve False Claims Act Allegations
4. MedQuist and Primordial to Demonstrate Integrated Applications at RSNA
5. MedQuist and Clario Form Partnership to Integrate zVision Radiology Practice Management Software with SpeechQ for Radiology
6. MedQuist Introduces SpeechQ for Radiology Integrated with RadWorkFlow
7. MedQuist Reports Third Quarter 2008 Results
8. MedQuist Reports Second Quarter 2008 Results
9. MedQuist Announces Changes to Board of Directors
10. MedQuist Announces Declaration of $2.75 per share Dividend on Common Stock
11. Award-Winning Massachusetts Hospital Selects MedQuist Enterprise Technology for Clinical Documentation and Speech Recognition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/24/2017)... ... August 24, 2017 , ... Lori ... the development and advances in Desensitization therapy to improve the outcomes of organ ... about his remarkable journey of his 25 years of research in developing therapies ...
(Date:8/24/2017)... ... August 24, 2017 , ... Prime candidates for home ... have a condition that needs further monitoring such as surgery, stroke, heart attack ... stable, such as diabetes, high blood pressure, heart/lung disease, arthritis and stroke. ...
(Date:8/23/2017)... ... 2017 , ... The Arc Mercer, Capitol County’s premier provider of programs and ... community organization for people with special needs. The group, the Special Needs Alliance for ... of New Jersey – but the first in the entire country! , SNAP was ...
(Date:8/23/2017)... ... 2017 , ... Drs. Steven White and Brad Haines are pleased to announce ... of this offer, valued at more than $300 per year, new patients can enjoy ... patients receive a complimentary professional whitening procedure. , Stained or yellowed tooth enamel ...
(Date:8/23/2017)... ... ... Awards have announced the winners of the Best of the IBA Awards in The 2017 ... in the 2017 IBAs were not able to apply for the Best of the IBA ... awards won in the IBAs with a Gold Stevie win counting for three points, a ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 2017   Mostyn Law and Gulf Coast Regional Blood ... . The Mostyn Law family has had 3 ... is why Mostyn Law is partnering with Gulf Coast ... its appreciation. Blood supplies are running low. Gulf Coast ... hospital needs in August. That is why the blood center reached ...
(Date:8/15/2017)... , Aug. 15, 2017  AOTI Inc. announced today that ... Therapy Inc., has recently opened a New York City Office in ... usage of its unique Topical Wound Oxygen (TWO 2 ) homecare ... the Accreditation Commission for Health Care (ACHC) under the company,s DMEPOS ... ...
(Date:8/8/2017)... -- BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused ... for the second quarter ended June 30, 2017. ... and to date: ... Company,s lead project, BL-8040: Announced plans ... novel stem cell mobilization treatment for autologous bone-marrow transplantation ...
Breaking Medicine Technology: